|Articles|September 1, 2019
- Applied Clinical Trials-09-01-2019
- Volume 28
- Issue 9
Applied Clinical Trials, September 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Improving Information Exchange in Clinical Trialsalmost 7 years ago
Workforce Readiness Technology Minimizes Risk in Clinical Trialsalmost 7 years ago
The Changing Landscape for Clinical Trial Sitesalmost 7 years ago
The VA Gets Real on Reformalmost 7 years ago
Creating Medicines ‘Appropriate for All’almost 7 years ago
Taking Care of Site Businessalmost 7 years ago
Proliferation of Rare Disease R&D Necessitating Novel Strategiesalmost 7 years ago
Retention Strategies for Keeping Participants EngagedAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
3
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5